PCVX (NASDAQ) director reported three 2,250-share sales and RSU/option items

Rhea-AI Filing Summary

PCVX reported proposed affiliate sales and recent dispositions by James Wassil.

The filing lists three prior open-market dispositions by James Wassil of 2,250 shares each on 04/01/2026, 05/01/2026, and 06/01/2026 with proceeds of $131,475.60, $127,870.65, and $111,416.62, respectively. The form also lists securities to be sold or issued to the issuer: 724 RSUs vesting 09/02/2025, 1,010 RSUs vesting 09/07/2025, and 516 shares from an exercise of stock options on 07/01/2026 (cash exercise).

Insights

Securities Compliance Officer

Routine Form 144 notice showing recent sales and scheduled issuances by an affiliate.

The excerpt lists three completed dispositions of 2,250 shares each on 04/01/2026, 05/01/2026, and 06/01/2026, with reported gross proceeds in the filing. It also records scheduled issuances: 724 RSUs, 1,010 RSUs, and 516 shares from option exercise on the dates provided.

These entries are typical affiliate sale notices; cash‑flow recipients and any trading plan language are not included in the excerpt. Subsequent filings would show final sale mechanics or net proceeds if material.

Key Figures

Disposition per tranche: 2,250 shares Gross proceeds: $131,475.60 Gross proceeds: $127,870.65 +4 more

7 metrics

Disposition per tranche 2,250 shares <date>04/01/2026</date> / <date>05/01/2026</date> / <date>06/01/2026</date>

Gross proceeds <money>$131,475.60</money> Proceeds from 2,250 shares on <date>04/01/2026</date>

Gross proceeds <money>$127,870.65</money> Proceeds from 2,250 shares on <date>05/01/2026</date>

Gross proceeds <money>$111,416.62</money> Proceeds from 2,250 shares on <date>06/01/2026</date>

RSUs vesting 724 RSUs Vesting date <date>09/02/2025</date>

RSUs vesting 1,010 RSUs Vesting date <date>09/07/2025</date>

Option exercise 516 shares Exercise on <date>07/01/2026</date> (cash)

Key Terms

Form 144, RSU Vest, Exercise of stock options

3 terms

Form 144 regulatory

"144: Securities Sold During The Past 3 Months"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

RSU Vest financial

"09/02/2025 | RSU Vest | Issuer"

Exercise of stock options financial

"07/01/2026 | Exercise of stock options | Issuer"

FAQ

What did the PCVX Form 144 report about James Wassil's recent sales?

It reports three dispositions of 2,250 shares each on 04/01/2026, 05/01/2026, and 06/01/2026. The filing lists the gross proceeds for each sale as $131,475.60, $127,870.65, and $111,416.62, respectively.

Which securities are listed as to be sold or issued in the PCVX excerpt?

The excerpt lists 724 RSUs vesting on 09/02/2025, 1,010 RSUs vesting on 09/07/2025, and 516 shares issuable from an option exercise on 07/01/2026 with a cash exercise method.

Do the filing entries show how the option exercise will be funded?

Yes; the exercise listed for 516 shares on 07/01/2026 is shown as a cash exercise in the excerpt. No further detail on proceeds use is provided in the excerpt.

Are the amounts listed in the Form 144 final sale amounts or proposed quantities?

The three transactions dated 04/01/2026–06/01/2026 are reported as completed dispositions with gross proceeds. The RSU vesting counts and option exercise quantity are listed as securities to be sold or issued on the stated dates.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/01/2026 - 04:02 PM Accepted by SEC EDGAR 07/01/2026 - 04:02 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001813798
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Vaxcyte, Inc.
SEC File Number	001-39323
Address of Issuer	825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CALIFORNIA 94070
Phone	650-837-0111
Name of Person for Whose Account the Securities are To Be Sold	Wassil Jim
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. 11 Madison Ave 4th Floor New York NY 10010	2250	130792.50	144397682	07/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/02/2025	RSU Vest	Issuer			724	09/02/2025	N/A
Common	09/07/2025	RSU Vest	Issuer			1010	09/07/2025	N/A
Common	07/01/2026	Exercise of stock options	Issuer			516	07/01/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
James Wassil 825 INDUSTRIAL ROAD STE. 300 SAN CARLOS CA 94070	Common	04/01/2026	2250	131475.60
James Wassil 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070	Common	05/01/2026	2250	127870.65
James Wassil 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070	Common	06/01/2026	2250	111416.62

144: Remarks and Signature

Remarks
Date of Notice	07/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/09/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc, as attorney-in-fact for James Wassil
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)